NCVH Shreveport | October 5, 2013

NCVH Shreveport

Thank you to all of the attendees, faculty members, and sponsors that participated in this year's Multidisciplinary Strategies for Advanced Treatment of Peripheral Artery Disease and Limb Preservation.

You will be able to download your Certificates starting October 11, 2013.

Join us for an exciting opportunity to earn CME/CE credit, enjoy great education, and network with local peers.

This meeting will focus on Peripheral Artery Disease (PAD) and advanced limb preservation techniques and technologies.

Registration includes accreditation, breakfast, lunch, and outstanding education by 10+ nationally recognized expert faculty members.

Accreditation will be provided for physicians, nurses, allied health professionals, and cath lab technologists.

Registration Fees


Please scroll to see the full Agenda.
Click on Session heading to expand/collapse.



Craig M. Walker, MD
Cardiovascular Institute of the South
Houma, LA

W. Britton Eaves, MD
Cardiovascular Consultants Willis Knighton Bossier Health System
Bossier, LA

Please scroll to see the full list of Faculty.
After clicking on a name click "Go Back" to return to the full list.



Physical (paper) accreditation certificates will not be issued onsite at this conference. All certificates will be available online by Friday, October 11, 2013.

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Global Education Group (Global) and New Cardiovascular Horizons. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this live activity for a maximum of 7.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the Multidisciplinary Strategies for Advanced Treatment of Peripheral Artery Disease and Limb Preservation (NCVH Shreveport).
Nursing Continuing Education
Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.
This educational activity for 7.75 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
American Society of Radiologic Technologists
This activity is approved for credit by the ASRT.
For information about the accreditation of this program, please contact Global at 303-395-1782 or
Target Audience
Family Physicians, General Practice Physicians, Primary Care Providers, Internists, Cardiologists, Interventional Cardiologists, Vascular Medicine Specialists, Podiatrists, Cath Lab Technologists, Residents/Fellows, Physician Assistants, Advanced Practice Nurses, Nurses, Allied Health Professionals and Healthcare Administrators.
Statement of Need/Program Overview
The Multidisciplinary Strategies for Advanced Treatment of Peripheral Artery Disease and Limb Preservation will focus on new developments, treatments, and technology available for patients with Peripheral Artery Disease, Critical Limb Ischemia, Non-Healing Lower Extremity Wounds, or who may be at risk for leg amputation.
Educational Objectives
After completing this activity, the participant should be better able to:

  • Select an optimal antiplatelet therapeutic strategy for each patient based on individualized patient characteristics and risk factors.
  • Analyze updated guidelines for ACS management, highlighting the role of newly available treatment options.
  • Differentiate between each of the available P2Y12 receptor antagonists using findings from clinical trials.

AF and Stroke

  • Discuss the clinical trial findings regarding the efficacy and safety profiles of the novel oral anticoagulants for the treatment of AF and stroke prevention.
  • Design an individualized treatment approach for each AF patient taking into account their risk of stroke and bleeding, renal status, and comorbidities.
  • Evaluate the most recent AHA/ASA clinical guidelines as well as other scientific advisories regarding optimal stroke prevention in patients with AF.


  • Determine individualized blood pressure target goals for patients with a variety of risk factors and comorbidities.
  • Evaluate clinical data that support the use of fixed-dose combination therapies, with or without thiazide diuretics.
  • Evaluate the most recent AHA/ASA clinical guidelines as well as other scientific advisories regarding optimal stroke prevention in patients with AF.
  • Develop a strategy for incorporating JNC 7, ASH, and forthcoming JNC 2013 guidelines into your own practice.


  • Determine individualized lipid goals for patients with a variety of secondary prevention cardiovascular risk factors
  • Analyze existing and new options for patients with treatment resistant familial hypercholesterolemia.
  • Develop a strategy for incorporating NCEP ATP III and forthcoming ATP IV guidelines into your own practice. 

Certificate Instructions
If you have any questions regarding accreditation or certificates, please visit the registration table located in the foyer outside of the meeting room. Physical accreditation certificates will not be issued at this conference. 
3 Easy Steps to Print Your Certificate:
1. Go to, login with your username and password (upper right corner of the website).
2. Click “Edit My Profile” and update your credentials and specialty to ensure you receive the correct certificate, click submit.
3. In your profile, locate “Shreveport 2013” and click “Complete Evaluation”. After completing the evaluation, your certificate will be available to download on the main profile page.
You will be asked to complete a brief survey to receive your certificate. If you have questions or need assistance, please contact us at 337-993-7920 or

Supported by an educational grant from Daiichi Sankyo, Inc.

Exhibitors / Sponsors

Thank You to our Past Exhibitors and Supporters for NCVH Shreveport:

Abbott Vascular
Access Closure, Inc.
ACIST Medical System
Angioslide, Ltd.
Arbor Pharmaceuticals
Atrium Medical
Avinger, Inc.
Bard Peripheral Vascular
Bayer Healthcare
Boston Heart Diagnostics
Boston Scientific
Cardiovascular Systems, Inc.
Cook Medical
Cordis Corporation
Gilead Sciences
Gore & Associates
IDEV Technologies, Inc.
Met-Test LLC.
Natural Molecular Testing
Pound Medical Consulting
Willis-Knighton Health System

Exhibit Levels: 
Platinum $ 3,000 
Gold $ 2,000 
Silver $ 1,500 
Supporter $ 1,000 
Discounted Rate $ 500 * 
*Available for Home Health Agencies or companies with fewer than 25 employees.


Additional Opportunities: 

Breakfast $ 2,000 
Lunch $ 3,000 
Additional Badge $ 100 
*Breakfast and lunch sponsors recognized on signage and in sponsor list.
Symposia to include non-accredited education available upon request for an additional fee.


Exhibit Details: 

• Space is limited to 35 table top exhibits 
• Space cannot be reserved without full payment 
• Exhibit spaces are 6’ x 30” table tops to include table cloth, table skirt, and 2 chairs 
• Send all shipments directly to meeting location 
• Exhibit services are not provided for this meeting


Area Airport
Shreveport Regional Airport - SHV
Shreveport-Bossier Convention and Visitor's Bureau


Anticoagulation and Platelet Therapy Session

8:00AM | W. Britton Eaves, MD | Craig Walker, MD
Opening Remarks:

8:15AM | Craig Walker, MD
What’s New on the Vascular Horizon: View PDF

8:30AM | Glenn Polin, MD
Analyzing Clinical Trial Findings of the Efficacy and Safety Profiles of Novel Anticoagulants for the Treatment of Atrial Fibrillation and Prevention of Stroke: View PDF

8:45AM | Anish Thomas, MD
Selecting an Optimal Antiplatelet Therapy for the ACS and CAD Patient: View PDF

9:00AM | W. Britton Eaves, MD
Differentiating Between the PTY-12 Receptor Antagonists and Clopidogrel: View PDF

9:15AM | Glenn Polin, MD
Differentiating Between Direct-Thrombin Inhibitors, Xa Inhibitors, and Warfarin for Anticoagulation in AF Patients: View PDF

9:30AM | Hugo Cuellar, MD
Advances in Management of Acute CVA: View PDF

9:45AM |
Questions and Answers/Panel Discussion:

10:00AM |

Lipids, Venous and Procedural Management Session

10:15AM | W. Britton Eaves, MD
Treating to Target Cholesterol Goals for Secondary-Prevention Patients: View PDF

10:25AM | Gaurav Aggarwala, MD
Understanding Various Lipid Disorders and Their Treatments: View PDF

10:40AM | Huey McDaniel, MD
Diagnosis and Treatment of May Thurner Syndrome: View PDF

10:50AM | W. Britton Eaves, MD
Aspiration Thrombectomy and Thrombolysis in PAD Management: View PDF

11:00AM | Rex Teeslink, MD
Alternative Drug Delivery Devices: What is Out There?: View PDF

11:10AM | Gaurav Aggarwala, MD
Treatment Strategy and Management of Deep Vein Thrombosis: View PDF

11:25AM | Stacey Wright, ACNP
Intraprocedural Nursing Care for the CLI Patient: View PDF

11:35AM | Rex Teeslink, MD
Endovascular Challenges of the Morbidly Obese Patient: View PDF

11:45AM |
Questions and Answers/Panel Discussion:

12:00PM |

Vascular Surgery and Endovascular Treatment Session

1:00PM | Vinay Kumar, MD
Endovascular Therapy has Virtually Replaced Surgery in the Treatment of Aortoiliac Occlusive Disease: View PDF

1:15PM | Neeraj Tandon, MD
Review of SFA and Iliac Interventional Trials: View PDF

1:30PM | Wayne Zhang, MD
Endovascular Treatment of Vascular Injuries: View PDF

1:45PM | Vinay Kumar, MD
Choosing Carotid Endarterectomy or Carotid Angioplasty with Stent Placement: How to Achieve Best Results: View PDF

2:00PM | James Bennett Jr, MD
OCT Imaging: Early Experience with Ocelot and Pantheris:

2:15PM | Wayne Zhang, MD
Treatment of Complex Aortic Aneurysms: View PDF

2:30PM |
Questions and Answers/Panel Discussion:

2:45PM |

Hypertension and Critical Limb Ischemia Session

3:00PM | W. Britton Eaves, MD
Acute Limb Ischemia: A Medical Emergency: View PDF

3:15PM | Bryan Randolph, DPM
Diagnosis, Treatment, and Management of Foot Ulcers: View PDF

3:30PM | Anish Thomas, MD
BTK Intervention: Antegrade, Retrograde and Transcollateral Intervention:

3:45PM | Victoria Everton, MD
Wound Care and Hyperbaric Treatment: View PDF

4:00PM | James Bennett Jr, MD
Comparing JNC-7 Treatment Guidelines with Emerging JNC-8 (JNC 2013): What Will be New and Different?: View PDF

4:15PM | Michael Rokaw, MD
Renovascular Hypertension with Renal Stenting and Ablation: View PDF

4:30PM | Claude Minor, MD
Current Indication for Renal Artery Stenting: View PDF

4:45PM | Huey McDaniel, MD
Understanding and Individualizing Effective Treatment for Hypertension: Focusing on Treatment-Resistant Cases: View PDF

5:00PM |
Questions and Answers/Panel Discussion:

5:10PM | W. Britton Eaves, MD
Closing Remarks:

5:15PM |

Connect and share with NCVH Online!